Remission among Thai adults with severe asthma
Remission in Adults With Severe Asthma in Thailand
This project will see how common remission is among adults in Thailand with severe asthma and look for links with symptoms, lung function, FeNO, and blood eosinophils.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 230 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Thammasat University Academic / other |
| Locations | 1 site (Pathum Thani) |
| Trial ID | NCT07328035 on ClinicalTrials.gov |
What this trial studies
This cross-sectional observational project will enroll Thai adults aged 18 and older with severe asthma to determine how many meet remission criteria. Participants complete two questionnaires (GINA and ACT), undergo spirometry and a FeNO measurement, and have a single blood draw for eosinophil count during one visit. The study will measure the prevalence of remission and analyze associations with symptom scores, lung function, airway inflammation, and blood eosinophils. Data collection occurs at Thammasat University in Pathum Thani.
Who should consider this trial
Good fit: Thai adults age 18 or older with a clinical diagnosis of severe asthma who can perform spirometry and FeNO testing.
Not a fit: People with milder asthma, those unable to perform spirometry or FeNO, or those who cannot travel to the single site in Pathum Thani are unlikely to receive direct benefit from participation.
Why it matters
Potential benefit: If successful, the findings could help clinicians understand how often remission occurs in severe asthma in Thailand and point to simple tests that help identify patients more likely to be in remission.
How similar studies have performed: Prior cross-sectional studies in other countries have reported remission rates and linked markers like FeNO and blood eosinophils, but data specifically for severe asthma in Thailand are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * severe asthma * age 18 years or older Exclusion Criteria: * inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test
Where this trial is running
Pathum Thani
- Narongkorn Saiphoklang — Pathum Thani, Thailand (Recruiting)
Study contacts
- Principal investigator: Narongkorn Saiphoklang — Thammasat University Faculty of Medicine
- Study coordinator: Narongkorn Saiphoklang, MD
- Email: M_narongkorn@hotmail.com
- Phone: +6629269794
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.